Morgan Stanley Downgrades Eli Lilly (LLY) to Equalweight
Morgan Stanley analyst David Risinger downgraded Eli Lilly (NYSE: LLY) from ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)